Search hospitals > South Carolina > Myrtle Beach
Carolina Regional Cancer Center
Claim this profileMyrtle Beach, South Carolina 29577
Conducts research for Prostate Cancer
Conducts research for Prostate Adenocarcinoma
Conducts research for Adenocarcinoma
Conducts research for Lung Cancer
Conducts research for Small Cell Lung Cancer
16 reported clinical trials
1 medical researcher
Summary
Carolina Regional Cancer Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Prostate Adenocarcinoma, Adenocarcinoma, Lung Cancer, Small Cell Lung Cancer and other specialties. Carolina Regional Cancer Center is involved with conducting 16 clinical trials across 14 conditions. There are 1 research doctors associated with this hospital, such as Frank A. Vicini.Area of expertise
1Prostate Cancer
Stage IV
synaptophysin positive
chromogranin positive
2Prostate Adenocarcinoma
Stage IV
Top PIs
Clinical Trials running at Carolina Regional Cancer Center
Prostate Cancer
Prostate Adenocarcinoma
Breast Cancer
Recurrence
Adenocarcinoma
Low Testosterone
Tumors
Bone Metastasis
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Relugolix + Radiation
for Advanced-Stage Prostate Cancer
This phase II trial tests whether relugolix and radiation therapy works to shrink tumors in patients with prostate cancer that has spread in a limited way to 1 to 5 other parts of the body (oligometastatic). Testosterone can cause the growth of prostate cancer cells. Relugolix lowers the amount of testosterone made by the body. This may help stop the growth of tumor cells that need testosterone to grow. Giving relugolix with radiation therapy may help lower the chance of prostate cancer growing or spreading.
Recruiting0 awards Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Carolina Regional Cancer Center?
Carolina Regional Cancer Center is a medical facility located in Myrtle Beach, South Carolina. This center is recognized for care of Prostate Cancer, Prostate Adenocarcinoma, Adenocarcinoma, Lung Cancer, Small Cell Lung Cancer and other specialties. Carolina Regional Cancer Center is involved with conducting 16 clinical trials across 14 conditions. There are 1 research doctors associated with this hospital, such as Frank A. Vicini.